- Clinical Trials
- December 2024
- 60 Pages
Global
From €1185EUR$1,250USD£990GBP
- Report
- May 2024
- 129 Pages
Global
From €6160EUR$6,499USD£5,146GBP
- Report
- March 2024
- 180 Pages
Global
From €7535EUR$7,950USD£6,295GBP
- Report
- May 2022
- 59 Pages
Global
From €1896EUR$2,000USD£1,584GBP
The Helicobacter Pylori Drug market is a subset of the Infectious Diseases Drugs market. It is composed of drugs used to treat Helicobacter pylori, a type of bacteria that can cause stomach ulcers and other gastrointestinal issues. These drugs are typically antibiotics, such as amoxicillin, clarithromycin, and metronidazole, and are often used in combination with other drugs. The Helicobacter Pylori Drug market is highly competitive, with many companies offering similar products.
Some of the major companies in the Helicobacter Pylori Drug market include Pfizer, Merck, GlaxoSmithKline, AstraZeneca, and Sanofi. These companies offer a variety of products, ranging from single-drug treatments to combination therapies. Additionally, many generic drug manufacturers also offer Helicobacter Pylori Drugs. Show Less Read more